Prednisolone Acetate 1% Ophthalmic Suspension, 10 mL — Lupin Pharmaceuticals

LupinSKU: RX-1053

THIS WEBSITE IS FOR DOCTORS ONLY. TO VISIT OUR RETAIL STORE CLICK HERE

Description

NDC: 61314-0637-10

Prednisolone Acetate 1% Ophthalmic Suspension, 10 mL — Lupin Pharmaceuticals

Active ingredient Prednisolone acetate 1%
Dosage form Ophthalmic suspension
Route Topical ophthalmic
Size 10 mL
Manufacturer Lupin Pharmaceuticals
NDC 61314-0637-10

Indications and Usage

A corticosteroid indicated for the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

Dosage and Administration

Shake well before use. Instill one to two drops into the conjunctival sac two to four times daily; during the initial 24 to 48 hours the dosing frequency may be increased if necessary. Reduce dosing gradually rather than discontinuing abruptly.

Warnings and Precautions

  • Prolonged use may cause glaucoma, elevated intraocular pressure, optic nerve damage, and posterior subcapsular cataract; monitor IOP if used 10 days or longer
  • May mask or enhance existing infection and suppress the host immune response
  • May thin the cornea or sclera and cause perforation; avoid in herpes simplex
  • Not for injection

Contraindications

Contraindicated in most viral diseases of the cornea and conjunctiva including herpes simplex keratitis, vaccinia and varicella, mycobacterial eye infection, fungal ocular disease, and hypersensitivity to any component.

Adverse Reactions

Reactions include elevated intraocular pressure and glaucoma, cataract formation, delayed wound healing, secondary ocular infection, and transient stinging or burning.

Storage and Handling

Store at 8°C to 24°C (46°F to 75°F) in an upright position.

How Supplied

Sterile 1% ophthalmic suspension in plastic dropper bottles, including 10 mL size.

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.

If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.

You may also like

Recently viewed